“Without diagnostics, medicine is blind.” (Alain Merieux)
The International Diagnostics Centre (IDC) envisions a world where every person has access to the quality diagnostics they need to maximise their chances of a healthy life.
The mission of the IDC at the London School of Hygiene & Tropical Medicine (LSHTM) is to facilitate the development, evaluation and implementation of accessible, quality assured in-vitro diagnostics (IVDs) for global health through information sharing and advocacy.
There are significant efforts underway to accelerate the development, evaluation, and implementation of diagnostics for global health, but the market for those products is inefficient. Information is at best asynchronous; there is no single, easily-accessed repository of information, including best practices, for market participants.
There is also a lack of impartial and timely dialogue between public and private stakeholders that could advance the implementation, uptake and sustainability of new IVDs.
The IDC seeks to make the market for diagnostics for global health more efficient by bridging the information gap in two ways:
- through its website, which is a rich digital platform of information, toolkits and e-learning, and
- by convening key stakeholders, including industry, to tackle issues and advance solutions.
The IDC brings together the wide-ranging academic and research resources of LSHTM and other stakeholders, on the one hand, and diagnostic companies, developers and international partners, on the other hand, to provide advocacy and a comprehensive website to assist those trying to design, develop and implement IVDs for global health.
Rosanna Peeling PHD
Rosanna Peeling is currently Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine (LSHTM) and Director of the International Diagnostics Centre (IDC). Trained as a medical microbiologist, Dr. Peeling had been Research Coordinator and Head of Diagnostics Research at the UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (WHO/TDR) in Geneva, Switzerland, and the Chief of the Canadian National Laboratory for Sexually Transmitted Diseases before assuming her current position. Her work in WHO/TDR focused on the evaluation of diagnostics appropriate for developing countries settings, to inform policy and procurement decisions. Dr Peeling’s work at LSHTM spans from facilitating test development and evaluation to translation of evidence to policy, appropriate placement of new diagnostic technologies into different health care settings to ensure maximum impact, and innovation in the uptake of testing by marginalised populations. She established the IDC to provide a global hub for advocating the value of diagnostics, fostering innovation, and accelerating regulatory approval and access to quality-assured diagnostics to improve global health. In 2014, she was awarded the George MacDonald Medal by the Royal Society of Hygiene and Tropical Medicine for contributions to tropical medicine, becoming the first woman to receive this honour.
Prof Peeling’s work in WHO/TDR focused on the evaluation of diagnostics to inform policy and procurement decisions in developing countries. She has also extensive experience conducting implementation research on the introduction of new diagnostics to ensure optimal uptake and sustainable adoption. At LSHTM, Prof Peeling established the International Diagnostics Centre with the aims of accelerating access to diagnostics in the developing world through reducing duplication of clinical trials, streamlining regulatory approval and accelerating policy development.
In collaboration with WHO/TDR and the University of Hong Kong, Prof Peeling is exploring the use of social innovation to build sustainable models of health service delivery in the developing world.
Joseph Tucker MD PHD
Joseph D. Tucker is an infectious diseases physician with a special interest in using public challenge contests to improve sexual health. He is an Associate Professor at the London School of Hygiene and Tropical Medicine and at the University of North Carolina at Chapel Hill School of Medicine. His team’s ongoing research investigates challenge contests to promote HIV, syphilis, HCV, and HBV testing. He is the Chairman of the Steering Committee of Social Entrepreneurship to Spur Health (SESH), a group focused on using public challenge contests to improve health. Many of his challenge contests have focused on promoting diagnostics, creating people-friendly diagnostic services, and enhancing uptake of diagnostics. He has contributed to several WHO guidelines and serves as a member of the TDR Global Working Group. Joe received his BA from Swarthmore, MD from UNC, AM (RSEA) from Harvard, and PhD from the London School of Hygiene and Tropical Medicine.
Noah Fongwen MD MPH
Dr Noah Fongwen currently a clinical research fellow and a Doctor of Public Health(Dr.PH) candidate at the Clinical Research Department(CRD) of the London School of Hygiene and Tropical Medicine(LSHTM). He also provides support to the Africa Centres for Disease Control(Africa CDC) through the LSHTM/Africa CDC collaboration. He is a global health expert skilled in advanced research methods, implementation science, economic evaluation of complex public health interventions and point of care technologies. He has expertise in areas such as diagnostics research, maternal and child health, HIV/TB control, NTDs and other chronic diseases, antimicrobial resistance control and outbreak response. He has worked in Cameroon as a clinician(M.D) and public health specialist for 5 years where he supported the government in implementing its public health strategies ranging from maternal and child health, vaccination, chronic diseases and outbreak response. He also works with WHO TDR and SIHI in promoting research within social innovation across Africa to ensure sustainability and political buy-in. He is keen on transforming evidence into policy and practice. His current doctor of public health research work is on transforming the Health Centre by Phone innovation in Malawi from a one-way means of providing health education to underserved populations to a two-way communications tool to provide alerts of infectious outbreaks and other health information such as vaccine coverage and to conduct research on how to replicate and scale up innovations in Africa.
Dr Noah Fongwen has more than 25 peer reviewed publications and several published systematic reviews. He is also a guest editor for a special 2019 issue of the African Journal of Laboratory Medicine, with theme: “The Future of Diagnostics”.
Eneyi Kpokiri BPharm MSc PhD
Eneyi Kpokiri, PhD is Post-doctoral Research Fellow in Social Innovation in Health based at the International Diagnostics Centre, LSHTM. She has conducted several innovation challenge contests in global health topics including clinical diagnostics and AMR and access to infectious disease diagnostics in LMICs. With a clinical pharmacy background, her doctoral research from the University College London, School of Pharmacy focused on improving antibiotics use by identifying strategies to support the implementation of effective antimicrobial stewardship programmes in low and middle-income settings. She has experience in health services research using participatory and qualitative methods. Her research is on exploring current public health services and practice patterns, identifying challenges and potential opportunities
Debi Boeras PhD
The Global Health Impact Group started by Debi Boeras in 2014 was formed in response to the need for stronger partnerships to meet global HIV targets. Debi brings with her over 10 years of HIV experience as a molecular virologist at Emory University Yerkes Primate Research Center and then as the Lead for Molecular Diagnostics at the International Laboratory Branch, Centers for Disease Control and Prevention. In Debi’s experience, the most efficient and effective approach to ensure successful programs in HIV diagnosis and monitoring is through strong collaborations. Debi continues to work closely with the African Society for Laboratory Medicine (ASLM), CDC and PEPFAR, Clinton Health Access Initiative (CHAI) and Doctors Without Borders (MSF), UNAIDS, UNITAID and the World Health Organization (WHO), providing laboratory and programmatic technical expertise to ensure sustainable country-owned health care programs and health systems.
Robert Luo MD MPH
Dr. Robert Luo, MD, MPH is a board-certified pathologist who has worked on diagnostics over the last 15 years across academia, public health, and industry. Dr. Luo received his BA from Harvard University and his MD and MPH from Johns Hopkins University, before completing his residency training in anatomic and clinical pathology at Stanford University. After residency, he worked at the US Centers for Disease Control and Prevention, Stanford University Medical Center, and most recently at Roche Molecular Diagnostics, where he served as a medical director for over 10 new diagnostic assays. His work on diagnostics and infectious diseases has been published in JAMA, Lancet, and numerous other scientific journals. He has lived and worked in a variety of settings, including the US, South Africa, China, Kenya, India, Peru, Vietnam, Malaysia, and North Korea.
Laura Broyles MD
Laura Broyles, MD is a board-certified infectious diseases physician with over 15 years experience in global HIV programs and clinical HIV care. Her work has included HIV viral load monitoring, early infant diagnosis, HIV drug resistance surveillance and research, elimination of mother-to-child transmission of HIV, differentiated service delivery for PLHIV, and ensuring quality HIV services at the facility level. Prior to joining GHIG, Laura spent eight years in the Division of Global HIV and TB (DGHT) at CDC headquarters in Atlanta, where she served most recently as Chief of the Maternal and Child Health Branch. Dr. Broyles served as an Epidemic Intelligence Service Officer in the CDC Division of HIV/AIDS Prevention from 2001-2003 after completing residency in internal medicine. She has been on the faculty of the Emory University Division of Infectious Diseases since 2006 and continues to do clinical work at the Grady Infectious Diseases Program.